People and Places in the News
- By BSTQ Staff
AWARDS
- CSL Behring has received a 2012 EURORDIS (European Organization for Rare Diseases) Award for its pioneering work in developing and manufacturing therapies used to treat rare and serious medical conditions. In 2011, the company received the National Organization for Rare Disorders Corporate Award for new treatments for rare diseases brought to market in the U.S.
GRANTS/DONATIONS
- Thomas Kodadek, a professor in the department of chemistry on the Scripps Florida campus, has been awarded $4.2 million from the National Institutes of Health in a program to advance what the agency calls “bold and creative research” into type 1 diabetes.
- The Mount Sinai Medical Center, Hoboken, N.J., is the second grant recipient of Octapharma’s 25th Anniversary Grants Program, which supports clinical or preclinical research focused on human protein therapies in hematology, immune therapy, intensive care and emergency medicine.
- CSL Behring has awarded six patient advocacy organizations in the U.S. with Local Empowerment for Advocacy Development (LEAD) grants totaling nearly $70,000. LEAD grants are awarded semiannually and are intended to help local patient organizations achieve their advocacy objectives by further developing an existing initiative or developing a new one. The grants were awarded to the Carolinas Healthcare Foundation, Neuropathy Action Foundation, Bleeding Disorder Foundation of Washington, Western Pennsylvania Chapter of NHF, the Bleeding Disorders Alliance of Illinois and the Bleeding Disorders Advocacy Network.
